ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

SPTX // Seaport Therapeutics Inc.

FA <GO> NASDAQ RQD COCKPIT → CIK 0002042347 ↗
Health Care • Biotechnology: Pharmaceutical Preparations
$20.01 ▲ +0.41 (+2.09%)
MKT CAP: $1.05B • VOL: 527.9K
SPTX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
Revenue (Total Sales) $104.6M
YoY Revenue Growth % —
Gross Profit —
Gross Margin % —
Research & Development (R&D) —
Operating Income (EBIT) $0
Operating Margin % —
Net Income (GAAP) $0
EBITDA (Normalized) —
Diluted EPS ($/sh) —
Operating Cash Flow (OCF) —
Capital Expenditures (CapEx) —
Free Cash Flow (FCF) —
FCF Margin % —
Return on Invested Capital (ROIC %) —
Cash & Short-Term Equivalents $46.0M
Total Debt (Short + Long Term) —
Total Stockholders' Equity -$92.5M